New treatment hope for menopausal depression

Professor Kulkarni said depression and anxiety was a major underreported and understudied effect of menopause.

A trial involving middle-aged Australian women is investigating the use of a hormone treatment for symptoms of menopausal depression.

Researchers at the Monash Alfred Psychiatry Research Centre (MAPrc) are trialling a hormone, known as Tibolone, to treat women with associated with menopause.

The trial will compare the use of Tibolone alone to treat depression as well as in conjunction with standard .

Principal investigator Professor Jayashri Kukarni, Director of MAPrc, said for most women, depression typically began in the pre-menopausal period five years or more before the onset of menopausal symptoms.

"During menopause, decline, which is associated with higher risk of depressive symptoms," Professor Kulkarni said.

"We know that the brain and mental state is affected by fluctuating hormone levels about five years earlier than the common physical symptoms of hot flushes and cessation of menstruation."

Professor Kulkarni said depression and anxiety was a major underreported and understudied effect of menopause.

"One of the main reasons that many women seek help from menopause clinics or their doctors is for depression and anxiety," Professor Kulkarni said.

"We hope that tibolone will reduce the severity of depressive symptoms, and in turn improve every day functioning for women with menopausal depression."

The study is currently recruiting women aged between 45 and 65 who have been diagnosed with or are currently experiencing depressive symptoms.

add to favorites email to friend print save as pdf

Related Stories

Research allows doctors to predict menopause symptoms

Feb 24, 2012

(Medical Xpress) -- Doctors could soon be able to predict the type and duration of menopausal symptoms an individual woman is likely to experience thanks to new findings from The University of Queensland (UQ).

Study shines new light on menopause symptoms

Apr 16, 2013

(Medical Xpress)—New UQ research reveals menopausal women who gain weight, smoke and consume alcohol at risky levels face an increased risk of experiencing night sweats and hot flushes.

Recommended for you

Brains transform remote threats into anxiety

Nov 21, 2014

Modern life can feel defined by low-level anxiety swirling through society. Continual reports about terrorism and war. A struggle to stay on top of family finances and hold onto jobs. An onslaught of news ...

Mental disorders due to permanent stress

Nov 21, 2014

Activated through permanent stress, immune cells will have a damaging effect on and cause changes to the brain. This may result in mental disorders. The effects of permanent stress on the immune system are studied by the ...

Could there be a bright side to depression?

Nov 21, 2014

(Medical Xpress)—A group of researchers studying the roots of depression has developed a test that leads them closer to the idea that depression may actually be an adaptation meant to help people cope with ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

FeleciaRose
5 / 5 (2) Aug 19, 2013
It's distressing how science continues to want to use chemicals to alleviate depression. Isn't it telling us something that we're playing with fire in light of the fact that medications aimed at making people happy also arouse irresistible impulses for suicide? The root problem is that the human animal is hardwired to linger over negative events and happiness research is teaching us we can train our brains to overcome this negative bias. Read about it here -- http://y55happy.c...raining/

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.